Related Experiment Video
Updated: Sep 26, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Risk assessment of hepatitis E transmission through tissue allografts
Rafael Villalba1, Vicente Mirabet2
1Center for Blood Transfusion, Tissues and Cells, Córdoba 14004, Spain.
Abstract:
Hepatitis E virus (HEV) is a small non-enveloped single stranded RNA virus whose genotypes 3 and 4 have been associated with zoonotic transmission in industrialized countries. HEV infection is considered the main cause of acute hepatitis worldwide. In some cases, transfusion of blood components or organ transplantation have been reported as the source of infection. We have conducted a literature review on the risk of transmission through cell and tissue allografts. Although no case was found, measures to control this risk should be taken when donor profile (based upon geographical and behavioural data) recommended it. Issues to be considered in donor screening and tissue processing to assess and to reduce the risk of HEV transmission are approached.
Insights
Hepatitis E virus (HEV) can spread through organ transplants. While no HEV transmission cases via cell and tissue allografts were found, screening donors is crucial for preventing HEV spread.
Area of Science:
- Virology
- Infectious Diseases
- Transplantation Immunology
Background:
- Hepatitis E virus (HEV) genotypes 3 and 4 are linked to zoonotic transmission in developed nations.
- HEV is a primary cause of acute hepatitis globally.
- Blood transfusion and organ transplantation are known routes of HEV infection.
Purpose of the Study:
- To review the risk of HEV transmission via cell and tissue allografts.
- To identify measures for controlling HEV transmission in allograft procedures.
Main Methods:
- Literature review on HEV transmission through allografts.
- Analysis of donor screening and tissue processing protocols.
Main Results:
- No documented cases of HEV transmission through cell and tissue allografts were identified.
- Geographical and behavioral data can inform donor risk assessment for HEV.
Conclusions:
- While no HEV transmission via allografts was found, proactive screening is recommended based on donor profiles.
- Implementing donor screening and optimized tissue processing can mitigate HEV transmission risks.
More Related Videos
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction

